Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
NCT02737462
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndrome
Interventions
DRUG:
CG200745 PPA
Sponsor
CrystalGenomics, Inc.